These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10400888)

  • 21. Repair of segmental defects in rabbit humeri with titanium fiber mesh cylinders containing recombinant human bone morphogenetic protein-2 (rhBMP-2) and a synthetic polymer.
    Murakami N; Saito N; Horiuchi H; Okada T; Nozaki K; Takaoka K
    J Biomed Mater Res; 2002 Nov; 62(2):169-74. PubMed ID: 12209936
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of recombinant human bone morphogenetic protein-2 on bone formation in alveolar ridge defects in dogs.
    Nagao H; Tachikawa N; Miki T; Oda M; Mori M; Takahashi K; Enomoto S
    Int J Oral Maxillofac Surg; 2002 Feb; 31(1):66-72. PubMed ID: 11936403
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New synthetic biodegradable polymers as BMP carriers for bone tissue engineering.
    Saito N; Takaoka K
    Biomaterials; 2003 Jun; 24(13):2287-93. PubMed ID: 12699665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone morphogenetic protein-2 enhances bone formation when delivered by a synthetic matrix containing hydroxyapatite/tricalciumphosphate.
    Jung RE; Weber FE; Thoma DS; Ehrbar M; Cochran DL; Hämmerle CH
    Clin Oral Implants Res; 2008 Feb; 19(2):188-95. PubMed ID: 18067602
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Repair of a proximal femoral bone defect in dogs using a porous surfaced prosthesis in combination with recombinant BMP-2 and a synthetic polymer carrier.
    Murakami N; Saito N; Takahashi J; Ota H; Horiuchi H; Nawata M; Okada T; Nozaki K; Takaoka K
    Biomaterials; 2003 Jun; 24(13):2153-9. PubMed ID: 12699651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Importance of delivery systems for growth-stimulatory factors in combination with osteopromotive membranes. An experimental study using rhBMP-2 in rat mandibular defects.
    Zellin G; Linde A
    J Biomed Mater Res; 1997 May; 35(2):181-90. PubMed ID: 9135167
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Augmentation of bone morphogenetic protein-induced bone mass by local delivery of a prostaglandin E EP4 receptor agonist.
    Toyoda H; Terai H; Sasaoka R; Oda K; Takaoka K
    Bone; 2005 Oct; 37(4):555-62. PubMed ID: 16027058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Formation and resolution of ankylosis under application of recombinant human bone morphogenetic protein-2 (rhBMP-2) to class III furcation defects in cats.
    Takahashi D; Odajima T; Morita M; Kawanami M; Kato H
    J Periodontal Res; 2005 Aug; 40(4):299-305. PubMed ID: 15966907
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Experimental studies on bone induction using low-molecular-weight poly (DL-lactide-co-glycolide) as a carrier for recombinant human bone morphogenetic protein-2.
    Bessho K; Carnes DL; Cavin R; Ong JL
    J Biomed Mater Res; 2002 Jul; 61(1):61-5. PubMed ID: 12001247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Experimental spinal fusion with recombinant human bone morphogenetic protein-2 delivered by a synthetic polymer and beta-tricalcium phosphate in a rabbit model.
    Namikawa T; Terai H; Suzuki E; Hoshino M; Toyoda H; Nakamura H; Miyamoto S; Takahashi N; Ninomiya T; Takaoka K
    Spine (Phila Pa 1976); 2005 Aug; 30(15):1717-22. PubMed ID: 16094272
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experimental spinal fusion using sintered bovine bone coated with type I collagen and recombinant human bone morphogenetic protein-2.
    Minamide A; Tamaki T; Kawakami M; Hashizume H; Yoshida M; Sakata R
    Spine (Phila Pa 1976); 1999 Sep; 24(18):1863-70; discussion 1871-2. PubMed ID: 10515009
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimization of entrapping conditions to improve the release of BMP-2 from PELA carriers by response surface methodology.
    Li X; Min S; Zhao X; Lu Z; Jin A
    Biomed Mater; 2014 Dec; 10(1):015002. PubMed ID: 25534880
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A study on a tissue-engineered bone using rhBMP-2 induced periosteal cells with a porous nano-hydroxyapatite/collagen/poly(L-lactic acid) scaffold.
    Zhang C; Hu YY; Cui FZ; Zhang SM; Ruan DK
    Biomed Mater; 2006 Jun; 1(2):56-62. PubMed ID: 18460757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Accelerated repair of a bone defect with a synthetic biodegradable bone-inducing implant.
    Matsushita N; Terai H; Okada T; Nozaki K; Inoue H; Miyamoto S; Takaoka K
    J Orthop Sci; 2006 Oct; 11(5):505-11. PubMed ID: 17013740
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Repair of long intercalated rib defects in dogs using recombinant human bone morphogenetic protein-2 delivered by a synthetic polymer and beta-tricalcium phosphate.
    Hoshino M; Egi T; Terai H; Namikawa T; Kato M; Hashimoto Y; Takaoka K
    J Biomed Mater Res A; 2009 Aug; 90(2):514-21. PubMed ID: 18563826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Local delivery of rolipram, a phosphodiesterase-4-specific inhibitor, augments bone morphogenetic protein-induced bone formation.
    Tokuhara Y; Wakitani S; Imai Y; Nomura C; Hoshino M; Yano K; Taguchi S; Kim M; Kadoya Y; Takaoka K
    J Bone Miner Metab; 2010; 28(1):17-24. PubMed ID: 19554392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ectopic osteoinduction and early degradation of recombinant human bone morphogenetic protein-2-loaded porous beta-tricalcium phosphate in mice.
    Liang G; Yang Y; Oh S; Ong JL; Zheng C; Ran J; Yin G; Zhou D
    Biomaterials; 2005 Jul; 26(20):4265-71. PubMed ID: 15683650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bone formation with use of rhBMP-2 (recombinant human bone morphogenetic protein-2).
    Zegzula HD; Buck DC; Brekke J; Wozney JM; Hollinger JO
    J Bone Joint Surg Am; 1997 Dec; 79(12):1778-90. PubMed ID: 9409791
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anterior thoracic spinal fusion in dogs by injection of recombinant human bone morphogenetic protein-2 and a synthetic polymer.
    Takahashi J; Saito N; Ebara S; Kinoshita T; Itoh H; Okada T; Nozaki K; Takaoka K
    J Spinal Disord Tech; 2003 Apr; 16(2):137-43. PubMed ID: 12679667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term stability of bone tissues induced by an osteoinductive biomaterial, recombinant human bone morphogenetic protein-2 and a biodegradable carrier.
    Kokubo S; Mochizuki M; Fukushima S; Ito T; Nozaki K; Iwai T; Takahashi K; Yokota S; Miyata K; Sasaki N
    Biomaterials; 2004 May; 25(10):1795-803. PubMed ID: 14738843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.